Gastrin Hormone Market Size

  • Report ID: 4036
  • Published Date: Apr 27, 2023
  • Report Format: PDF, PPT

Gastrin Hormone Market Size

Gastrin Hormone Market size is estimated to reach USD 1.2 Billion by the end of 2035, growing at a CAGR of 5% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of gastrin hormone was over USD 784 Million. The major reason for the global market growth during the forecast period is the rising cases of digestive disorders among the global population. As gastrin hormone stimulates the release of gastric acid, it plays an imperative role in the digestive process which has the ability to break down the proteins in the food that is consumed. Thus, with the rising cases of digestive disorders cases, the need for effective gastrin hormone is raised for bringing the digestion process back to normal. According to data found in a survey, it was found that in 2020, digestive diseases affected almost 60 million to 70 million people, which caused around 4 million hospitalizations, 70 million ambulatory-care visits, and 240,000 deaths in the North American region.

Gastrin hormones are effective medical products that are considered to be high-quality hormones that are produced by the wall of the pyloric end of the stomach in humans. It is highly effective in digestion processes and is responsible for enhancing gastric mucosal growth, gastric motility, and secretion of hydrochloric acid (HCI) into the stomach. The global gastrin hormone market is estimated to foresee tremendous growth owing to the increasing digestion-related diseases, obesity due to improper digestion, and deficiency of gastrin hormone in the body. Furthermore, gut infections along with illnesses occurring in the stomach are other factors that are anticipated to bring favorable opportunities for the expansion of the market during the forecast period.

Gastrin Hormone Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar

  • Report ID: 4036
  • Published Date: Apr 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of gastric diseases, such as gastritis, is estimated to boost the market growth.

The market size of gastrin hormone is anticipated to attain a CAGR OF 5% over the forecast period, i.e., 2023-2035.

Side effects associated with over secretion of gastric acid along with the less awareness level about gastric diseases are some of the factors that are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are RayBiotech Life, Inc., KareBay Biochem, Inc., Cayman Chemical Company, Cambridge Bioscience Limited, CPC Scientific Inc., Abcepta, GenScript Biotech Corporation, Qingdao Echemi Technology Co., Ltd., VWR International, LLC., and other key players.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by salt type, packaging size, end-user, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying